Extrait

To determine if LY2495655 administered in combination with chemotherapy improves overall survival (OS), compared to chemotherapy in combination with placebo in patients with Stage II-IV unresectable pancreatic cancer

Critère d'inclusion

• Muscle wasting and weakness associated with cancer of the pancreas that is locally advanced or metastatic

Liens

• euctr
• ictrp
• euctr
• euctr
• ictrp
• ictrp